Blar i Department of Clinical Science på tidsskrift "Orphanet Journal of Rare Diseases"
Viser treff 1-2 av 2
-
Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study
(Journal article; Peer reviewed, 2023)Background Pegunigalsidase alfa is a novel, PEGylated α-galactosidase-A enzyme-replacement therapy approved in the EU and US to treat patients with Fabry disease (FD). Objective/methods BRIDGE is a phase 3 open-label, ... -
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity
(Peer reviewed; Journal article, 2014-09-26)Background: A subset of hereditary cerebellar ataxias is inherited as autosomal recessive traits (ARCAs). Classification of recessive ataxias due to phenotypic differences in the cerebellum and cerebellar structures is ...